InvestorsHub Logo
Post# of 252235
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 152727

Tuesday, 11/20/2012 8:31:09 AM

Tuesday, November 20, 2012 8:31:09 AM

Post# of 252235
BTW, CSL had a safety problem with the 1st gen plasma derived drug in phase II and started all over with CSL-112.

The higher-dosage CSL-111 treatment group was discontinued early because of liver function test abnormalities.

http://www.ncbi.nlm.nih.gov/pubmed/17387133

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.